25 February 2022
Arix Bioscience Plc (the "Company")
Closed Period Notification
In accordance with the provisions of the UK Market Abuse Regulation ("UK MAR"), the Company announces that it has today entered into a closed period which will remain in place until the Company publishes its annual financial results for the year ended 31 December 2021, with an expected publication date of early April, to be confirmed.
The Company confirms that it is satisfied that all inside information which the Directors and the Company may have had to the date of this announcement has been notified to a Regulatory Information Service. Accordingly, the Company is not prohibited from dealing in its own securities during this closed period. In the event that the Directors and the Company come into possession of any further insider information during the closed period, this will be notified to a Regulatory Information Service in accordance with UK MAR.
For and on behalf of the Company,
Deirdre Quinn
Derringtons Limited, Company Secretary
Enquiries: +44 (0) 20 8819 6486
Companysecretary@derringtons.com